Virtual Clinical Trials Market Is Driven By The Increasing Healthcare Digitization
Virtual Clinical Trials Industry Overview The global virtual clinical trials market size was estimated at 7.8 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.7% from 2022 to 2030. The COVID-19 pandemic has significantly impacted the market. The market is majorly driven by a rise in R&D activities, the increasing healthcare digitization, as well as adoption of telehealth. Besides, technological advancements, alliances between clinical research organizations, pharmaceutical, and biotechnology companies as well as supportive government initiatives are anticipated to drive the market. The pandemic of COVID-19 is making the clinical trial industry change the way of conducting ongoing or upcoming trials. Gather more insights about the market drivers, restrains and growth of the Global Virtual Clinical Trials Market As per the continuum clinical report published in April 2020, approximately 30% of the surveyed...